SHL Telemedicine Ltd (SHLTN) Fair Value & Analysis
Healthcare · CH · Market cap CHF 38.9M
Fair value as of: Jul 16, 2026
From 2 valuation models · updated today
Share price +5.5% over the past month.
Price vs Fair Value (12 months)
12‑month range CHF 0.4565 – CHF 1.39 · fair‑value band CHF 1.07 – CHF 1.60 · the CHF 0.9600 price screens below the CHF 1.33 fair value. As of Jul 16, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
SHL Telemedicine Ltd (SHLTN) currently trades at CHF 0.9600, while our model-based Fair Value estimate is CHF 1.33, implying the stock looks roughly 39.0% undervalued today. We read business quality at 36/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.
Over the trailing twelve months, SHL Telemedicine Ltd generated revenue of CHF 58.7M at a net margin of -26.2%. Revenue grew 6.5% year over year. It earns a return on equity of -37.1%. The balance sheet holds a net cash position of CHF 12.2M. Fundamentals as of Jul 16, 2026
Our scenario range runs from CHF 1.07 (bear case) to CHF 1.60 (bull case); at CHF 0.9600, the current price sits below that range. The share trades about 35% below its 52-week high and 149% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -37% fair-value upside, at 39%, SHLTN screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 16, 2026. TTM = trailing twelve months.
About the company
SHL Telemedicine Ltd., together with its subsidiaries, provides telemedicine services in Israel, Europe, and internationally. The company offers SmartHeart platform, a 12-lead electrocardiogram (ECG) that enables a full, hospital-quality ECG to be performed by a lay-person without the assistance of a healthcare professional. It also provides preventative healthcare, including annual medical check-ups that include comprehensive laboratory tests, stress ECG tests, eye exams, and others; witness services for medical experts and medical committees; and occupational healthcare, including occupational safety and health regulated medical exams, exposure to hazardous materials, and occupational disability claims, as well as assisting organizations in promoting early detection of diseases and medical conditions within the workforce by offering periodical check-ups and specialized examinations. In addition, the company offers medical examinations, including at home, for the underwriting of …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
SHL Telemedicine Ltd reported revenue of CHF 61.5M in FY2025 versus CHF 49.6M in FY2021, a compound +5.5%/yr. Reported net income was −CHF 16.1M in FY2025.
Is SHLTN fairly valued? → Check now
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $163.76 | $103.58 | -37% |
| Pro Medicus Limited PME | A$165.64 | A$28.02 | -83% |
| BrightSpring Health Services, Inc BTSG | $60.59 | $23.87 | -61% |
| Tempus AI, Inc TEM | $48.61 | $12.67 | -74% |
| HealthEquity, Inc HQY | $89.72 | $54.47 | -39% |
| Hinge Health, Inc HNGE | $70.38 | $31.17 | -56% |
| M3, Inc MTHRY | $5.20 | $5.32 | +2% |
| 10x Genomics, Inc TXG | $31.04 | $20.68 | -33% |
| Waystar Holding WAY | $17.31 | $14.54 | -16% |
| Ping An Healthcare and Technology Company PANHF | $0.9000 | $0.5700 | -37% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is SHL Telemedicine Ltd (SHLTN) undervalued?
What is the fair value of SHLTN?
What is the quality score of SHLTN?
What is the revenue of SHL Telemedicine Ltd (SHLTN)?
What is the net profit margin of SHLTN?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Tell me when SHL Telemedicine Ltd reaches its Fair Value
Just your email, and we'll notify you when the price and Fair Value of SHL Telemedicine Ltd materially change. Free bonus: the monthly Top-25 report of the most undervalued quality stocks.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.